Name | Weis Pharmacy #128 |
---|---|
Organization Name | Weis Markets Inc |
Location | 2205 Hanover Pike, Hampstead, Maryland 21074 |
Type | Supplier |
Phone | (410) 374-4019 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Caretek Medical Ltd, an Oxford-based company developing an innovative needle-free drug delivery system, today announced that it has signed a feasibility study agreement with a major global pharmaceutical company.
Uncontrolled diabetes increases maternal and fetal risks during pregnancy. As a result, the American Diabetes Association recommends that family planning should be discussed and effective contraception should be available to the more than three percent of (more than one million) reproductive-age women in the United States with diabetes.
Array BioPharma Inc. today announced the presentation of positive Phase 1 clinical data for its novel kinesin spindle protein inhibitor, ARRY-520. The data, which were presented at the 2010 Annual Meeting of the American Society of Hematology in Orlando, Florida, indicate that ARRY-520 was well tolerated and has shown encouraging preliminary results in the treatment of multiple myeloma.
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
According to a new landmark study published in The New England Journal of Medicine, infusions of clotting factor VIII used preventively can significantly reduce the risk of developing joint damage associated with joint bleeding in young children with hemophilia A.
› Verified 6 days ago
News Archive
Caretek Medical Ltd, an Oxford-based company developing an innovative needle-free drug delivery system, today announced that it has signed a feasibility study agreement with a major global pharmaceutical company.
Uncontrolled diabetes increases maternal and fetal risks during pregnancy. As a result, the American Diabetes Association recommends that family planning should be discussed and effective contraception should be available to the more than three percent of (more than one million) reproductive-age women in the United States with diabetes.
Array BioPharma Inc. today announced the presentation of positive Phase 1 clinical data for its novel kinesin spindle protein inhibitor, ARRY-520. The data, which were presented at the 2010 Annual Meeting of the American Society of Hematology in Orlando, Florida, indicate that ARRY-520 was well tolerated and has shown encouraging preliminary results in the treatment of multiple myeloma.
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
According to a new landmark study published in The New England Journal of Medicine, infusions of clotting factor VIII used preventively can significantly reduce the risk of developing joint damage associated with joint bleeding in young children with hemophilia A.
› Verified 6 days ago
Family Pharmacy Inc Type: Pharmacy Location: 907 S Main St, Hampstead, Maryland 21074 Phone: (410) 239-3100 | |
Cvs Pharmacy # 04220 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2311 Hanover Pike, Hampstead, Maryland 21074 Phone: (410) 239-3750 | |
Wal-mart Pharmacy 10-2850 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2320 Hanover Pike, Hampstead, Maryland 21074 Phone: (410) 374-0332 | |
Weis Pharmacy #128 Type: Medicare Supplier Location: 2205 Hanover Pike, Hampstead, Maryland 21074 Phone: (410) 374-4019 | |
Weis Pharmacy 139 Type: Pharmacy Location: 720 Hanover Pike, Hampstead, Maryland 21074 Phone: (410) 374-1422 |